The Hypoxostat Model: A Conceptual Framework Linking Hypoxia, Oxidative Stress and Periodontal Breakdown Under Orthodontic Load
Antioxidants · 12.03.2026 · 15 (3) · 363
DOI: 10.3390/antiox15030363 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 12.03.2026. Verfasst von Anna Ewa Kuc und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentofacial Orthopedics and Orthodontics, Wroclaw Medical University, 50-425 Wroclaw, Poland. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hypoxic and oxidative stress states tightly regulate bone and periodontal remodeling, yet the field lacks an integrated conceptual framework explaining how fluctuating oxygen availability and redox signaling determine anabolic versus catabolic outcomes. Although hypoxia-inducible factor-1α (HIF-1α), reactive oxygen species (ROS), and reperfusion injury are individually well-studied, their coordinated role in defining tissue remodeling thresholds remains unclear.
Methods
This Perspective synthesizes mechanistic evidence from cellular, molecular, and tissue-level studies on hypoxia, redox biology, perfusion dynamics, osteoimmunology, and bone remodeling. Published data were evaluated to characterize how oxygen tension, ROS generation, and inflammatory signaling interact under mechanical or metabolic stress. A conceptual model (“Hypoxostat Model”) was constructed to describe the regulatory balance between hypoxia-driven catabolism and oxygenation-driven anabolism. Hypothesis: The Hypoxostat Model proposes that tissues operate within a dynamic oxygen-dependent regulatory window. Moderate hypoxia transiently activates HIF-1α, angiogenesis, and osteogenic compensation, whereas deeper or sustained hypoxia collapses perfusion, increases ROS, amplifies IL-1β/TNF-α/IL-17A signaling, and promotes RANKL-mediated osteoclastogenesis. Reoxygenation phases trigger additional oxidative bursts, further biasing tissues toward destructive remodeling. Thin periodontal phenotypes exhibit reduced perfusion reserve and increased sensitivity to hypoxia–ROS transitions, lowering their threshold for entry into catabolic remodeling domains.
Conclusions
Hypoxia and redox signaling function as a bistable regulatory system controlling bone and periodontal remodeling. The Hypoxostat Model provides a unifying framework linking oxygen tension, ROS dynamics, inflammatory cytokines, and remodeling outcomes. Recognizing hypoxia–reoxygenation behavior as a mechanistic switch may improve prediction of tissue vulnerability and guide therapeutic strategies aimed at modulating redox balance or enhancing local perfusion.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dentofacial Orthopedics and Orthodontics, Wroclaw Medical University, 50-425 Wroclaw, Poland.
- Faculty of Medicine, Medical University in Bialystok, ul. Kilińskiego 1, 15-089 Białystok, Poland.
- Department of Periodontology and Operative Dentistry, University of Münster, 48149 Münster, Germany.
- Department of Integrated Dentistry, Wroclaw Medical University, 50-425 Wroclaw, Poland.
ORCID-Profile: Anna Ewa Kuc, Laurentia Schuster, Michał Sarul
Zitieren
APA
Kuc, A. E., Kuc, P., Schuster, L., & Sarul, M. (2026). The Hypoxostat Model: A Conceptual Framework Linking Hypoxia, Oxidative Stress and Periodontal Breakdown Under Orthodontic Load. Antioxidants, 15(3), 363. https://doi.org/10.3390/antiox15030363
Vancouver
Kuc AE, Kuc P, Schuster L, Sarul M. The Hypoxostat Model: A Conceptual Framework Linking Hypoxia, Oxidative Stress and Periodontal Breakdown Under Orthodontic Load. Antioxidants. 2026;15(3):363. doi:10.3390/antiox15030363
BibTeX
@article{Kuc2026,
author = {Kuc, Anna Ewa and Kuc, Paulina and Schuster, Laurentia and Sarul, Michał},
title = {The Hypoxostat Model: A Conceptual Framework Linking Hypoxia, Oxidative Stress and Periodontal Breakdown Under Orthodontic Load},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {3},
pages = {363},
doi = {10.3390/antiox15030363}
}
EUVIMED